• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Saturday, November 11, 2006 5:30 PM to 9:30 PM

Article

A CME Evening Symposium and Reception

A CME Symposium and Reception held
during the AAO 2006 
Joint Meeting

Saturday, November 11, 2006
The Venetian Resort Hotel Casino
3355 Las Vegas Blvd S
Las Vegas, Nevada

REGISTER ON LINE
OR CALL TOLL FREE
888-248-0036

5:30 PM to 6:30 PM Registration
6:30 PM to 8:00 PM CME Symposium
8:00 PM to 9:30 PM Reception

Program Chairman and Moderator

Michael A. Lemp, MDClinical Professor of Ophthalmology
Georgetown University
George Washington University
Washington, DC

Faculty

Alejandro Aguilar, MDOphthalmology Specialist
Grupo Médico Las Lomas
San Isidro, Argentina

Maurizio Rolando, MDAssociate Professor
Department of Neurosciences, Ophthalmology, and Genetics
The University of Genoa
Genoa, Italy

Allan R. Slomovic MA, MD, FRCS(C)Associate Professor of Ophthalmology
University of Toronto
Toronto Western Hospital
Toronto, Ontario

Target Audience
This educational activity is intended for comprehensive ophthalmologists.

Statement of Need and Activity Description
Dysfunctional tear syndrome ("dry eye") is one of the most common reasons patients visit their ophthalmologist. Patient complaints are subjective and diagnosis, as well as determination of severity, can often be difficult since the etiology of dry eye is multifactorial and complex. In recent years, diagnostic methods have increased as understanding of the disease has advanced. In addition, new treatment modalities have become available that provide options for patients. Since this chronic disease is so often encountered in practice, it is important for ophthalmologists to keep current with the newest diagnostic and treatment approaches to meet the individual needs of a full range of patients for long-term effective management.

Learning Objectives

Agenda

6:30 PM–6:35 PM—Welcome and IntroductionMichael A. Lemp, MD

6:35 PM–6:50 PM—Overview of pathogenesis of dry eye
Michael A. Lemp, MD

6:50 PM–7:05 PM—Diagnosing dry eye/assessment of severity
Allan R. Slomovic MA, MD, FRCS(C)

7:05 PM–7:20 PM—A Contemporary Approach to the New Patient with Dry Eye
Alejandro Aguilar, MD7:20 PM–7:35 PM—Constructing a Long-term Management Plan for Dry Eye
Maurizio Rolando, MD

7:35 PM–8:00 PM—Q & A Session

8:00 PM–9:30 PM—Cocktail Reception

Accreditation Statement
This continuing medical education activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The New York Eye and Ear Infirmary and cme2, an independent subsidiary of Advanstar Communications Inc, publisher of Ophthalmology Times. The New York Eye and Ear Infirmary is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The New York Eye and Ear Infirmary designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy Statement
The New York Eye and Ear Infirmary requires that each participant/teacher in a CME-accredited educational activity disclose the existence of any financial interest and/or other relationship(s) (eg, paid speaker, employee, paid consultant on a board and/or committee for a commercial company) that would potentially affect the objectivity of his/her presentation. Speakers are also asked to make a disclosure that a product is still investigational when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity. The disclosed information in no way presumes to assess the participant's qualifications or suitability. The intention is to provide full disclosure of any potential conflict of interest, real or perceived, which is related to a specific event. Full disclosure of faculty and commercial relationships, if any, will be made at the program.

Provider Disclosure
The New York Eye and Ear Infirmary received a financial benefit from Alcon Laboratories, Inc to administer this educational activity.

PRE-REGISTER ON LINE
or call 888-248-0036
or 218-740-7130

Related Videos
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.